HRS8179

· Beijing Suncadia Pharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HRS8179, covering 2025-01-06 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction [Phase 2, Phase 3]

See pricing